Literature DB >> 16915529

Assessment of no-reflow regions using cardiac MRI.

Timothy S E Albert1, Raymond J Kim, Robert M Judd.   

Abstract

Ischemic myocardial injury can be broadly characterized as either reversible or irreversible. Within irreversibly injured (infarcted) regions microvascular perfusion can vary from nearly normal to nearly zero, even in the presence of an open infarct-related artery ('no-reflow'). Historically, non-invasive assessment of heterogeneous microvascular perfusion within myocardial infarcts has been problematic. More recently, however, contrast-enhanced MRI has emerged as a promising approach to the examination of these regions in patients with myocardial infarction. In this review we highlight a number of important animal and human studies of no-reflow regions examined using contrast-enhanced MRI. These studies provide evidence that contrast- enhanced MRI can accurately characterize the presence and spatial extent of no-reflow regions, discriminate between areas of necrosis with and without no-reflow, and provide clinically meaningful predictive information regarding left ventricular remodeling and patient outcome.

Entities:  

Mesh:

Year:  2006        PMID: 16915529     DOI: 10.1007/s00395-006-0617-0

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  11 in total

Review 1.  Imaging of stem cells using MRI.

Authors:  Dara L Kraitchman; Jeff W M Bulte
Journal:  Basic Res Cardiol       Date:  2008-03       Impact factor: 17.165

2.  Acute myocardial infarction: early CT aspects of myocardial microcirculation obstruction after percutaneous coronary intervention.

Authors:  Charles Amanieu; Ingrid Sanchez; Simona Arion; Eric Bonnefoy; Didier Revel; Philippe Douek; Loic Boussel
Journal:  Eur Radiol       Date:  2013-05-08       Impact factor: 5.315

3.  The role of first-pass perfusion deficit in the detection of cardiac subendocardial manifestation in patients with autoimmune vasculitis.

Authors:  Alexander Pfeil; Gabriele Lehmann; Joachim Böttcher; Gunter Wolf; Andreas Hansch
Journal:  Rheumatol Int       Date:  2012-01-03       Impact factor: 2.631

4.  Performance of CMR Methods for Differentiating Acute From Chronic MI.

Authors:  Martijn W Smulders; Sebastiaan C A M Bekkers; Han W Kim; Lowie M R Van Assche; Michele A Parker; Raymond J Kim
Journal:  JACC Cardiovasc Imaging       Date:  2015-05-14

5.  MRI manifestations of persistent microvascular obstruction and acute left ventricular remodeling in an experimental reperfused myocardial infarction.

Authors:  Yuesong Yang; John J Graham; Kim Connelly; Warren D Foltz; Alexander J Dick; Graham A Wright
Journal:  Quant Imaging Med Surg       Date:  2012-03

Review 6.  Cell therapy in myocardial infarction: emphasis on the role of MRI.

Authors:  Yuxiang Ye; Jan Bogaert
Journal:  Eur Radiol       Date:  2007-10-09       Impact factor: 5.315

7.  Role of contrast-enhanced magnetic resonance imaging in detecting early adverse remodeling and subacute ventricular wall rupture complicating myocardial infarction.

Authors:  Unni Krishnan; Gerry P McCann; Mark Hickey; Matthias Schmitt
Journal:  Heart Vessels       Date:  2008-11-27       Impact factor: 2.037

8.  Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation.

Authors:  K Hoetzenecker; A Assinger; M Lichtenauer; M Mildner; T Schweiger; P Starlinger; A Jakab; E Berényi; N Pavo; M Zimmermann; C Gabriel; C Plass; M Gyöngyösi; I Volf; H J Ankersmit
Journal:  Basic Res Cardiol       Date:  2012-08-17       Impact factor: 17.165

9.  The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised controlled trial.

Authors:  Sheraz A Nazir; Jamal N Khan; Islam Z Mahmoud; John P Greenwood; Daniel J Blackman; Vijay Kunadian; Martin Been; Keith R Abrams; Robert Wilcox; A A Jennifer Adgey; Gerry P McCann; Anthony H Gershlick
Journal:  Trials       Date:  2014-09-25       Impact factor: 2.279

10.  Cardiac injuries in blunt chest trauma.

Authors:  Marina Huguet; Catalina Tobon-Gomez; Bart H Bijnens; Alejandro F Frangi; Marius Petit
Journal:  J Cardiovasc Magn Reson       Date:  2009-09-17       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.